Your browser doesn't support javascript.
loading
Correction to: Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis.
Wang, Jiayu; Xu, Binghe; Wang, Wenna; Zhai, Xiaoyu; Chen, Xuelian.
Affiliation
  • Wang J; Department of Medical Oncology, National Cancer Centre/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, #17 Panjiayuan Nanli, Beijing, China.
  • Xu B; Department of Medical Oncology, National Cancer Centre/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, #17 Panjiayuan Nanli, Beijing, China. bhxu@hotmail.com.
  • Wang W; Department of Medical Oncology, National Cancer Centre/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, #17 Panjiayuan Nanli, Beijing, China.
  • Zhai X; Department of Medical Oncology, National Cancer Centre/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, #17 Panjiayuan Nanli, Beijing, China.
  • Chen X; Department of Medical Oncology, National Cancer Centre/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, #17 Panjiayuan Nanli, Beijing, China.
Breast Cancer Res Treat ; 173(2): 487, 2019 01.
Article in En | MEDLINE | ID: mdl-30470975
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Systematic_reviews Language: En Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Systematic_reviews Language: En Year: 2019 Type: Article